BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29016740)

  • 1. A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.
    Huang C; Liu Y; Beenken A; Jiang L; Gao X; Huang Z; Hsu A; Gross GJ; Wang YG; Mohammadi M; Schultz JEJ
    Cardiovasc Res; 2017 Nov; 113(13):1585-1602. PubMed ID: 29016740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.
    Strande JL; Widlansky ME; Tsopanoglou NE; Su J; Wang J; Hsu A; Routhu KV; Baker JE
    Cardiovasc Res; 2009 Jul; 83(2):325-34. PubMed ID: 19380418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury.
    House SL; Castro AM; Lupu TS; Weinheimer C; Smith C; Kovacs A; Ornitz DM
    Am J Physiol Heart Circ Physiol; 2016 Mar; 310(5):H559-71. PubMed ID: 26747503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
    Bao W; Holt LJ; Prince RD; Jones GX; Aravindhan K; Szapacs M; Barbour AM; Jolivette LJ; Lepore JJ; Willette RN; DeAngelis E; Jucker BM
    Cardiovasc Diabetol; 2013 Oct; 12():148. PubMed ID: 24125539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
    Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
    Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats.
    Deschamps AM; Murphy E
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1806-13. PubMed ID: 19717735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
    Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
    Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
    Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes.
    Alloatti G; Arnoletti E; Bassino E; Penna C; Perrelli MG; Ghé C; Muccioli G
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H470-81. PubMed ID: 20525876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sevoflurane post-conditioning protects isolated rat hearts against ischemia-reperfusion injury via activation of the ERK1/2 pathway.
    Xie H; Zhang J; Zhu J; Liu LX; Rebecchi M; Hu SM; Wang C
    Acta Pharmacol Sin; 2014 Dec; 35(12):1504-13. PubMed ID: 25345742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
    Zhong B; Wang DH
    Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
    Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
    Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium 4-Phenylbutyrate Attenuates Myocardial Reperfusion Injury by Reducing the Unfolded Protein Response.
    Takatori O; Usui S; Okajima M; Kaneko S; Ootsuji H; Takashima SI; Kobayashi D; Murai H; Furusho H; Takamura M
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):283-292. PubMed ID: 27909014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.
    Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chrysin rescues rat myocardium from ischemia-reperfusion injury via PPAR-γ/Nrf2 activation.
    Rani N; Arya DS
    Eur J Pharmacol; 2020 Sep; 883():173389. PubMed ID: 32707190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
    Durst R; Danenberg H; Gallily R; Mechoulam R; Meir K; Grad E; Beeri R; Pugatsch T; Tarsish E; Lotan C
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3602-7. PubMed ID: 17890433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.
    Dai W; Hale SL; Kay GL; Jyrala AJ; Kloner RA
    Cardiovasc Ther; 2010; 28(1):30-7. PubMed ID: 20074257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.